YD Bio reports peer-reviewed Nutrients publication on omega-3, vitamins D3 and K2 "heart-brain-bone" axisPUBT·4 hours agoYDES-0.43%
U.S. Stock Market Midday Update: YD Bio Soars 109% in 10 Days Without Any Good News? Speculative Trading May Carry Adjustment RisksPrice Alert·Aug 20 at 01:48 PMYDES-0.43%
U.S. stock market midday update: YD Bio up 14.54% with no positive news? Capital influx shows volatility, reasons to be observedPrice Alert·Aug 18 at 12:13 PMYDES-0.43%
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Dayrttnews·Aug 17 at 09:13 PMPFSA-8.73%GNPX-0.50%
U.S. Stock Market Midday Update: YD Bio Rises 31.9% in Five Days Without Positive News? Capital Inflows Drive VolatilityPrice Alert·Aug 17 at 02:43 PMYDES-0.43%
YD Bio highlights peer-reviewed computational study nominating keratoconus regenerative therapy targetsPUBT·Aug 4 at 07:07 AMYDES-0.43%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 7 at 12:05 PMCRNX+0.07%AKTX+4.95%
Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Updaterttnews·Jul 6 at 10:12 PMSEER+1.23%LUCYW-26.16%
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection OperationsUnusual Whales·Jul 2 at 07:02 AMYDES-0.43%
YD Bio wins Rhode Island, Pennsylvania lab licenses, expanding U.S. footprint to 46 statesPUBT·Jul 2 at 07:01 AMYDES-0.43%
12 Health Care Stocks Moving In Tuesday's Pre-Market Sessionbenzinga_article·Jun 16 at 07:05 AMYDES-0.43%HITI+2.24%
U.S. stock market midday update: YD Bio down 14.13% with increased volume and sharp decline, no major negative news, intensified capital speculation causing volatilityPrice Alert·Jun 4 at 01:48 PMYDES-0.43%
